High-dose erythropoietin in patients with progressive multiple sclerosis: A randomized, placebo-controlled, phase 2 trial

Karen Schreiber, Per Soelberg Sørensen, Bjarne Laursen et al.|Multiple Sclerosis Journal|2016

Cited by 53